Active Infection & Immunity Public Health & Healthcare

Vaccinology

In plain English

AI plain-English summary

Africa still lacks effective vaccines for HIV, major outbreak viruses, and parasitic worm infections like schistosomiasis—and even existing vaccines work less well in poor, rural, tropical communities than elsewhere. This research theme tackles that gap head-on. It does not study vaccines in isolation; it asks why vaccines fail or succeed differently across communities, and what can be done about it. The team will develop and test new vaccines in African clinical trials—for example, a vaccine against Rift Valley Fever, a virus that causes recurring outbreaks in humans and livestock across East Africa. They will also investigate how to combine vaccines with other HIV prevention tools, determine optimal dosing schedules for different age groups, and study how communities learn about, perceive, and build confidence in vaccines. If successful, the work could lead to new vaccines for diseases that currently have none, and to practical strategies—dosing schedules, delivery methods, community engagement approaches—that make existing vaccines work more equitably. The project also builds vaccine research expertise among African scientists, strengthening the continent’s capacity to respond to its own infectious disease priorities.

View original technical description
Vaccines are among the most successful tools available for protecting public health, but effective vaccines are still lacking for many infectious diseases that are important in Africa – including HIV, viruses that cause major outbreaks in African populations, and parasitic diseases including worm infections. As well, vaccines work better in some communities than others, with poor communities in rural, low-income, tropical settings often at a disadvantage. Our theme will contribute to • Developing new vaccines of particular importance for Africa, and testing them in clinical trials – for example vaccines against viruses such as Rift Valley Fever which causes outbreaks among humans and farm animals in East Africa, and against debilitating worm infections such as schistosomiasis • Understanding how best to employ vaccines in Africa – for example how vaccines can be combined with other preventive measures against HIV, or what the most appropriate dosing schedules are for particular age groups and needs • Investigating why some vaccines work differently in different communities, and working with communities to develop strategies that enable them to benefit from vaccines to the full • Understanding how different communities learn about, understand and perceive vaccines, and what makes people confident to use them • Building vaccine research expertise among African researchers This work will contribute to ensuring that African communities secure the maximum possible benefit from vaccines.

View the original record at the funder ↗

Related Research

Grants with similar aims, by meaning.

NIHR Global Health Research Group on Vaccines for vulnerable people in Africa (VAnguard)
Thematic Support - Vaccines and Immunity
NIHR Global Health Research Group on Gastrointestinal Infections: Facilitating the Introduction and Evaluation of Vaccines for Enteric Diseases in Children in Eastern and Southern sub-Saharan Africa
NIHR Global Health Research Group on Vaccines to Control Respiratory Pathogens & AMR across Africa (VacAMR)
OptiVaNTS – Optimising Vaccination for iNTS disease in Africa

Original classification

Intramural

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.